SPONSOR
Eye & ENT Hospital of Fudan University
Total Trials
6
Recruiting
6
Phases
Phase 2, EARLY_Phase 1
Conditions studied: TinnitusAmblyopia UnilateralHead and Neck NeoplasmsRecurrent DiseaseMetastatic CancerSquamous Cell Carcinoma of External Auditory CanalLocally Advanced TumorBacterial KeratitisAntibiotic-resistant BacteriaInfections, Bacterial
Eye & ENT Hospital of Fudan University is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Tinnitus, Amblyopia Unilateral, Head and Neck Neoplasms, Recurrent Disease.
The trial portfolio spans Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Eye & ENT Hospital of Fudan University
How many clinical trials has Eye & ENT Hospital of Fudan University sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Eye & ENT Hospital of Fudan University, of which 6 are actively recruiting participants. These trials cover conditions including Tinnitus, Amblyopia Unilateral, Head and Neck Neoplasms. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Eye & ENT Hospital of Fudan University research focus on?
Eye & ENT Hospital of Fudan University clinical trials span Tinnitus, Amblyopia Unilateral, Head and Neck Neoplasms, Recurrent Disease, Metastatic Cancer, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Eye & ENT Hospital of Fudan University clinical trial?
To participate in a Eye & ENT Hospital of Fudan University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Eye & ENT Hospital of Fudan University trials with current recruitment status updated daily.
Clinical Trials by Eye & ENT Hospital of Fudan University
NCT06635967
Recruiting
The Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Subjective Tinnitus
Tinnitus
NCT06498206
Recruiting
AR Training Versus Patching in Unilateral Amblyopia
Amblyopia Unilateral
NCT05260671 Phase 2
Recruiting
Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN
Head and Neck Neoplasms
NCT07370337 Phase 2
Recruiting
Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal
Squamous Cell Carcinoma of External Auditory Canal
NCT06451172 EARLY_Phase 1
Recruiting
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
Bacterial Keratitis
NCT06151743 Phase 2
Recruiting
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma
Locally Advanced Hypopharyngeal Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology